IVD China this week: Roche and Deep Informatics, Danaher, Merck, Fapon and Stanford Healthcare Innovation Lab

Fapon Biotech and Stanford Healthcare Innovation Lab reached strategic cooperation

Recently, Fapon Biotech reached a strategic cooperation with Stanford Healthcare Innovation Lab and became an industrial member of its affiliated program. In the future, both parties will carry out in-depth academic research and scientific cooperation in the field of healthcare.

As an industry member of the affiliated project at Stanford University, Fapon Biotech will collaborate with research experts from the Lab to explore the cutting-edge technologies in the industry and connect with high potential startups to inject new momentum into Fapon Biotech 's global research strength. In November this year, Fapon Biotech will be invited to participate in the Mental Healthcare Innovation Summit at Stanford University.

Danaher has reached strategic cooperation with Beijing Changping District government

On September 5th, Danaher, a global innovator in science and technology, signed a strategic cooperation agreement with the Changping District government to jointly promote the construction of Danaher North Science and Technology Innovation Center and a leading innovation service platform in synthetic biology.

This cooperation once again demonstrates Danaher's confidence and determination in maintaining a positive outlook on the Chinese market. In the process of greater efforts in local industrial chain and ecological construction, Danaher aims to deepen government-enterprise cooperation, accelerate the upgrading of the big health industry, and assist Healthy China 2030.

Shenzhen Guangming District government and Merck signed a strategic cooperation agreement

Recently, Shenzhen Guangming District government and Merck signed a strategic cooperation agreement on the Guangming District Public Service Platform, marking the official landing of the Merck’s South China Center Guangming Science City project.

The joint construction of the South China Center Guangming Science City project will fully leverage Merck's resource advantages and the platform advantages of the Guangming Science City to promote international exchanges, provide overall solutions for the industry and promote the clustering and development of the biopharmaceutical industry.

Roche Diagnostics and Deep Informatics collaborate to jointly launch a pathology AI-assisted interpretation algorithm

On September 6th, Roche Diagnostics China announced its official partnership with Deep Informatics. They will jointly launch a pathology artificial intelligence (AI) assisted interpretation algorithm product, further promoting the digitalization and intelligent transformation of pathology diagnosis in China, providing strong support for the development of personalized precision diagnosis and treatment. 

​​​

View full report https://en.caclp.com/industry-news/2421.html